- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/20 - Oxygen atoms
Patent holdings for IPC class C07D 307/20
Total number of patents in this class: 360
10-year publication summary
|
29
|
31
|
26
|
16
|
23
|
16
|
16
|
33
|
19
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Corsair Pharma, Inc. | 37 |
14 |
| Archer Daniels Midland Company | 1129 |
13 |
| Reata Pharmaceuticals Holdings, LLC | 49 |
9 |
| Zevra Therapeutics, Inc. | 103 |
9 |
| ChromaDex Inc. | 97 |
8 |
| Alphora Research Inc. | 25 |
7 |
| The Queen's University of Belfast | 262 |
7 |
| Gilead Sciences, Inc. | 2106 |
6 |
| Boehringer Ingelheim International GmbH | 4636 |
5 |
| Vertex Pharmaceuticals Incorporated | 1630 |
5 |
| Daicel Corporation | 2411 |
5 |
| Novomer, Inc. | 212 |
5 |
| University of Kansas | 894 |
5 |
| Bristol-myers Squibb Company | 4826 |
4 |
| Syngenta Participations AG | 1730 |
4 |
| Shin-Etsu Chemical Co., Ltd. | 5795 |
4 |
| President and Fellows of Harvard College | 6043 |
4 |
| SK Innovation Co., Ltd. | 1382 |
4 |
| Tereos Starch & Sweeteners Belgium | 29 |
4 |
| Eisai R&D Management Co., Ltd. | 1204 |
4 |
| Other owners | 234 |